Ensysce Biosciences, Inc.
ENSC· Nasdaq
Ensysce Biosciences, Inc.
- Last sale
- Oct 1, 2026 · -3.94%
- Market cap
- $7.83M
- 19.46M shares
- Filings
- 543
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,066,650 | reported | |
| FY 2024 | 2024-12-31 | $5,210,031 | reported | |
| FY 2023 | 2023-12-31 | $2,230,520 | reported | |
| FY 2022 | 2022-12-31 | $2,523,383 | reported | |
| FY 2021 | 2021-12-31 | $3,531,199 | reported |
Ensysce Biosciences, Inc. · CIK 1716947 · Engraved from SEC EDGAR
